A new emerging hallmark of cancer

January 25, 2016

Normally, tissues demonstrate a slightly acidic intracellular pH (pHi) and slightly alkaline extracellular pH (pHe). However, proliferating tissues demonstrate transient pH Gradient Reversal i.e. alkalinization of pHi and acidification of pHe. Persistent and magnified pH Gradient Reversal is a hallmark of cancer. High acidic pHe is toxic to normal cells and beneficial to tumor cells giving them a proliferative advantage. It further augments tumorigenesis by upregulating proteolysis, genomic instability, immunosuppression, thereupeutic resistance and angiogenesis. A more basic pHi on the other hand protects tumors from acidic pHe induced apoptosis and enhances their proliferation. This event occurs quite early and is essential for tumorigenesis. It increases the activity of glycolytic enzymes, resulting in the augmented production of cancerous building blocks. It inhibits the cell cycle arrest mediated by DNA damage and promotes G2-M transition. This, allows for unrestricted proliferation and accumulation of genetic instability in tumor cells.

The pH Gradient Reversal can possibly be considered as the most distinct cancer specific abnormality and a mandatory event universally present in all kinds of cancerous cells and tissues. Furthermore, it is manifest even during the commencement of tumorigenesis and is essential for the survival and proliferation of tumors, irrespective of their pathology, genetics and origins. Based on these facts, we propose a novel hallmark of cancer - "pH gradient reversal". A low salt diet enriched with fruits and vegetables due to its alkaline nature can minimize pH Gradient Reversal by the tumors, therby reducing their aggressive nature and therapeutic resistance. Moreover, therapies specifically targeting this tumor hallmark are likely to offer a valuable adjunct to the conventional ones focused exclusively on killing tumor cells, and even replace the older, more toxic and non-selective therapeutic strategies. We firlmy believe that this hallmark should be added to the list of already existing ones.
-end-
Dr. Mohit Sharma, Dr. Madhusudan Astekar, Dr. Sonal Soi, Dr. Bhari S. Manjunatha, Dr. Devi C. Shetty and Dr. Raghu Radhakrishnan.

Department of Oral Pathology and Microbiology, ITS-CDSR, India.

Bentham Science Publishers

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.